Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection
Christine M. McIntosh, … , Anita S. Chong, Maria-Luisa Alegre
Christine M. McIntosh, … , Anita S. Chong, Maria-Luisa Alegre
Published September 7, 2023
Citation Information: J Clin Invest. 2023;133(21):e168465. https://doi.org/10.1172/JCI168465.
View: Text | PDF
Research Article

Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection

  • Text
  • PDF
Abstract

Even when successfully induced, immunological tolerance to solid organs remains vulnerable to inflammatory insults, which can trigger rejection. In a mouse model of cardiac allograft tolerance in which infection with Listeria monocytogenes (Lm) precipitates rejection of previously accepted grafts, we showed that recipient CD4+ TCR75 cells reactive to a donor MHC class I–derived peptide become hypofunctional if the allograft is accepted for more than 3 weeks. Paradoxically, infection-induced transplant rejection was not associated with transcriptional or functional reinvigoration of TCR75 cells. We hypothesized that there is heterogeneity in the level of dysfunction of different allospecific T cells, depending on duration of their cognate antigen expression. Unlike CD4+ TCR75 cells, CD4+ TEa cells specific for a peptide derived from donor MHC class II, an alloantigen whose expression declines after transplantation but remains inducible in settings of inflammation, retained function in tolerant mice and expanded during Lm-induced rejection. Repeated injections of alloantigens drove hypofunction in TEa cells and rendered grafts resistant to Lm-dependent rejection. Our results uncover a functional heterogeneity in allospecific T cells of distinct specificities after tolerance induction and reveal a strategy to defunctionalize a greater repertoire of allospecific T cells, thereby mitigating a critical vulnerability of tolerance.

Authors

Christine M. McIntosh, Jennifer B. Allocco, Peter Wang, Michelle L. McKeague, Alexandra Cassano, Ying Wang, Stephen Z. Xie, Grace Hynes, Ricardo Mora-Cartín, Domenic Abbondanza, Luqiu Chen, Husain Sattar, Dengping Yin, Zheng J. Zhang, Anita S. Chong, Maria-Luisa Alegre

×

Figure 2

The presentation of donor MHCII–derived peptide declines during tolerance.

Options: View larger image (or click on image) Download as PowerPoint
The presentation of donor MHCII–derived peptide declines during toleranc...
(A) Cardiac allograft infiltrating CD45+ hematopoietic cells expressing MHCII. Native represents B/c hearts directly taken ex vivo. Grafts from Tol mice were analyzed between days 1 and 74 after transplantation. Native (n = 7), days 1–2 (n = 3), days 8–9 (n = 3), days 16–18 (n = 3), day 74 (n = 2). Significance not pictured: native versus days 1–2 (****), native versus days 8–9 (****), native versus days 16–18 (****), native versus days 74 (****). *P < 0.05, ****P < 0.0001. (B) Experimental design for C and E. Mice were transplanted with a B/c heart, and tolerance was induced with αCD154/DST (CoB). Thirty-five days after transplantation, CFSE-labeled CD45.1+TCR75/Rag–/– (TCR75) or CD45.1+TEa/Rag–/– (TEa) cells were adoptively transferred (Tol). Some control mice received a B/c heart without CoB 3 days prior to TCR-Tg cell transfer (AR). Other control mice were immunized with B/c splenocytes the same day as the TCR-Tg adoptive transfer (UnTx+DST). One subset of tolerant mice received extra alloantigen in the form of B/c splenocytes on the day of TEa transfer (Tol+DST). In all cases, TCR-Tg T cells were recovered 4 days after adoptive transfer and evaluated for CFSE dilution. (C) Representative histograms showing CFSE dilution in TCR75 or TEa cells 4 days after adoptive transfer into the groups described in B. (D and E) Summary data of CFSE dilution in TCR75 (D) or TEa (E) cells 4 days after adoptive transfer into the groups described in B. Data are represented as mean ± SEM. For D, UnTx (n = 6), UnTx+DST (n = 5), AR (n = 6), Tol (n = 6). For E, UnTx (n = 6), UnTx+DST (n = 4), AR (n = 5), Tol (n = 6), Tol+DST (n = 3). Significance not pictured: UnTx versus UnTx+DST (****), UnTx+DST versus Tol (****), Tol versus Tol+DST (***). (F) Representative histograms of donor MHCII (I-Ad/I-Ed) expression on graft-derived CD45–CD31+H2Kd+ endothelial cells. Data are representative of summary data shown in Figure 5B. Data were compared by 1-way ANOVA with Bonferroni’s correction for multiple pairwise comparisons (A, D, and E) or unpaired 2-tailed t test (F). P < 0.05 was considered significant. ***P < 0.001, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts